Hero image with Pittsburgh background pittplusme.org/study/1017

STUDY BASICS

Are you a woman age 40 or up who has been newly diagnosed (past 3 months) with non-invasive ductal carcinoma in situ (DCIS)? If so, you may be eligible for a study to help researchers evaluate the risks and benefits of usual treatment approach for DCIS vs. close monitoring approach. Study participation will last at least 5 years.


IRB:
  STUDY19030152 - HCC 16-207, COMPARING AN OPERATION TO MONITORING, WITH OR WITHOUT ENDOCRINE THERAPY (COMET) FOR LOW RISK DCIS: A PHASE III PROSPECTIVE RANDOMIZED TRIAL

Age Range
AGE:   40 and older

 
Gender List
SEX ASSIGNED AT BIRTH:   Female

Duration DURATION:  At least 5 years

Location LOCATION: 
Magee-Women’s Hospital of UPMC
Compensation COMPENSATION: 

NONE

Phone Number PHONE NUMBER:
1-866-438-8230
SHARE STUDY
Printer Printer   Email A FriendEmail A Friend   ShareShare   TweetTweet   Linked-InLinked-In
Search Icon pittplusme.org/study/1017
OR
Phone Number PHONE NUMBER:
1-866-438-8230

PittPlusMe.org 1-866-438-8230 PittPlusMe@pitt.edu
@PittPlusMe share tweet